Skip to ContentSkip to Navigation
How to find us C. Roselli


Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease

Genetic risk and atrial fibrillation in patients with heart failure

Genetics of Atrial Fibrillation in 2020 GWAS, Genome Sequencing, Polygenic Risk, and Beyond

Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction

Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score Results From the FOURIER Trial

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Transcriptional and Cellular Diversity of the Human Heart

Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation A Mendelian Randomization Study

Genetic risk prediction of atrial fibrillation in a contemporary heart failure cohort

Read more